|
| 35980763 | A polygenic risk score predicts atrial fibrillation in cardiovascular disease. | Eur Heart J | 2023 |
| 37556796 | Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes. | Diabetes Care | 2023 |
| 37494772 | Frequency, compliance, and yield of cardiac testing after high-sensitivity troponin accelerated diagnostic protocol implementation. | Am J Emerg Med | 2023 |
| 37454754 | A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH). | Am Heart J | 2023 |
| 37344040 | Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus. | J Am Coll Cardiol | 2023 |
| 37203441 | Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials. | Circ Heart Fail | 2023 |
| 36882341 | Race, ethnicity, sex, and socioeconomic disparities in anticoagulation for atrial fibrillation: A narrative review of contemporary literature. | J Natl Med Assoc | 2023 |
| 36691960 | Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P-TIMI 50 trial. | Clin Cardiol | 2023 |
| 36915035 | Remote Cardiovascular Hypertension Program Enhanced Blood Pressure Control During the COVID-19 Pandemic. | J Am Heart Assoc | 2023 |
| 36802880 | Pulling Out All the Stops: A Case of Progressive Dyspnea. | Circulation | 2023 |
| 36350612 | Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10⿯000 Patients Across a Diverse Health Care Network. | JAMA Cardiol | 2023 |
| 34481756 | Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program. | Am Heart J | 2022 |
| 35727760 | Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data. | PLoS One | 2022 |
| 35639852 | "The Doctor Is Out": New Tactics and Soldiers for Our Losing Battle Against Hypertension. | Circulation | 2022 |
| 35603596 | Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. | Circulation | 2022 |
| 35855557 | Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P-TIMI 50 trial. | Clin Cardiol | 2022 |
| 35715946 | Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4)Â inhibitors. | Clin Cardiol | 2022 |
| 35874460 | Use of automatic SQL generation interface to enhance transparency and validity of health-data analysis. | Inform Med Unlocked | 2022 |
| 36053173 | I2b2-etl: Python application for importing electronic health data into the informatics for integrating biology and the bedside platform. | Bioinformatics | 2022 |
| 36153643 | A remote hypertension management program clinical algorithm. | Clin Cardiol | 2022 |
| 33813934 | Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice. | J Pharm Pract | 2022 |
| 35081283 | Up in the Air. | N Engl J Med | 2022 |
| 35260841 | Tirzepatide for diabetes: on track to SURPASS current therapy. | Nat Med | 2022 |
| 35017308 | Magnetic Resonance Spectroscopy of Hypoxic-Ischemic Encephalopathy After Cardiac Arrest. | Neurology | 2022 |
| 35017304 | Regional Distribution of Brain Injury After Cardiac Arrest: Clinical and Electrographic Correlates. | Neurology | 2022 |
| 33201729 | Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control. | Circulation | 2021 |
| 33840228 | Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36. | J Am Heart Assoc | 2021 |
| 33587654 | Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials. | Circulation | 2021 |
| 33776428 | The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial. | Int J Chron Obstruct Pulmon Dis | 2021 |
| 33832610 | Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial. | J Am Coll Cardiol | 2021 |
| 33606921 | Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial. | Diabetes Obes Metab | 2021 |
| 33884889 | Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50. | J Am Heart Assoc | 2021 |
| 34528220 | Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial. | Adv Ther | 2021 |
| 34686204 | Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers. | Respir Res | 2021 |
| 34622665 | Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 Trial. | J Am Heart Assoc | 2021 |
| 34535469 | A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes. | Diabetes Care | 2021 |
| 34797832 | Assessing reproducibility and utility of clustering of patients with type 2 diabetes and established CV disease (SAVOR -TIMI 53 trial). | PLoS One | 2021 |
| 33200891 | Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. | N Engl J Med | 2021 |
| 33434447 | Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease. | Circ Genom Precis Med | 2021 |
| 33185476 | Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease. | Circulation | 2021 |
| 31567402 | Racial and Ethnic Disparities in Postcardiac Arrest Targeted Temperature Management Outcomes. | Crit Care Med | 2020 |
| 32000630 | Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial. | Vasc Med | 2020 |
| 31725920 | Rationale and design of a navigator-driven remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction. | Clin Cardiol | 2020 |
| 31986098 | Response by Bergmark et al to Letter Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial". | Circulation | 2020 |
| 33089909 | Practice pattern of use of high sensitivity troponin in the outpatient settings. | Clin Cardiol | 2020 |
| 33218988 | NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes? | Diabetes Care | 2020 |
| 32936209 | Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction. | JAMA Cardiol | 2020 |
| 32245636 | Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk. | Am J Cardiol | 2020 |
| 32164882 | Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. | J Am Coll Cardiol | 2020 |
| 30582181 | Development of an entirely remote, non-physician led hypertension management program. | Clin Cardiol | 2019 |